⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BLCO News
Bausch + Lomb Corporation
Form 8-K
sec.gov
BLCO
Form 8-K
sec.gov
BLCO
Bausch + Lomb Posts Strong Third-Quarter Performance, Raises Full-Year 2026 Guidance
businesswire.com
BLCO
Form 8-K
sec.gov
BLCO
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 Guidance
businesswire.com
BHC
BLCO
Bausch + Lomb Advances Novel Oral Treatment for Dry AMD Following Constructive FDA Meeting
businesswire.com
BLCO
Bausch + Lomb Will Release Third-Quarter 2026 Financial Results on Oct. 28
businesswire.com
BLCO
Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results
businesswire.com
BLCO
The Galien Foundation Unveils the 2026 Prix Galien EcoHealth Award Nominees
prnewswire.com
BLCO
CRC
Form 8-K/A
sec.gov
BLCO